Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target

Figure 1

TFR1 is overexpressed in gastric cancer tissues. (a) TFR1 expressed in representative tumor tissues and noncancerous tissues in GC. (b) The TFR1 expression was different in tumor and noncancerous tissues (n=155). (c) The GC patients with positive TFR1 expression had a better OS than that with negative TFR2 expression. (d–f) The different prognostic value of TFR1 expression in different GC cohort in K–M plotter databases.

(a)

(b)

(c)

(d)

(e)

(f)